Skip to main content Accessibility help

Mitochondrial calcium uniporter as a potential therapeutic strategy for Alzheimer’s disease

  • Anila Venugopal (a1), Mahalaxmi Iyer (a2), Venkatesh Balasubramanian (a1) and Balachandar Vellingiri (a1)


Alzheimer’s disease (AD), a neurodegenerative disorder, is the leading cause of dementia in the world whose aetiology is still unclear. AD was always related to ageing though there have been instances where people at an early age also succumb to this disease. With medical advancements, the mortality rate has significantly reduced which also makes people more prone to AD. AD is rare, yet the prominent disease has been widely studied with several hypotheses trying to understand the workings of its onset. The most recent and popular hypothesis in AD is the involvement of mitochondrial dysfunction and calcium homeostasis in the development of the disease though their exact roles are not known. With the sudden advent of the mitochondrial calcium uniporter (MCU), many previously known pathological hallmarks of AD may be better understood. Several studies have shown the effect of excess calcium in mitochondria and the influence of MCU complex in mitochondrial function. In this article, we discuss the possible involvement of MCU in AD by linking the uniporter to mitochondrial dysfunction, calcium homeostasis, reactive oxygen species, neurotransmitters and the hallmarks of AD – amyloid plaque formation and tau tangle formation.


Corresponding author

Author for correspondence: Balachandar Vellingiri, Email:


Hide All
Alzheimer’s ACHW (2017) Calcium hypothesis of Alzheimer’s disease and brain aging: a framework for integrating new evidence into a comprehensive theory of pathogenesis. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association 13(2), 178.
Antony, AN, Paillard, M, Moffat, C, Juskeviciute, E, Correnti, J, Bolon, B, Rubin, E, Csordás, G, Seifert, EL, Hoek, JB and Hajnóczky, G (2016) MICU1 regulation of mitochondrial Ca2+ uptake dictates survival and tissue regeneration. Nature Communications 7, 10955.
Baughman, JM, Perocchi, F, Girgis, HS, Plovanich, M, Belcher-Timme, CA, Sancak, Y, Bao, XR, Strittmatter, L, Goldberger, O, Bogorad, RL, Koteliansky, V and Mootha, VK (2011) Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter. Nature 476(7360), 341.
Calingasan, NY, Uchida, K and Gibson, GE (1999) Protein‐bound acrolein. Journal of Neurochemistry 72(2), 751756.
Connolly, J, Siderowf, A, Clark, CM, Mu, D and Pratico, D (2008) F2 isoprostane levels in plasma and urine do not support increased lipid peroxidation in cognitively impaired Parkinson disease patients. Cognitive and Behavioral Neurology 21(2), 8386.
Coppotelli, G and Ross, JM (2016) Mitochondria in ageing and diseases: the super trouper of the cell. International Journal of Molecular Sciences 17(5), 711.
Csordás, G, Golenár, T, Seifert, EL, Kamer, KJ, Sancak, Y, Perocchi, F, Moffat, C, Weaver, D, de la Fuente Perez, S, Bogorad, R, Koteliansky, V, Adijanto, J, Mootha, VK and Hajnóczky, G (2013) MICU1 controls both the threshold and cooperative activation of the mitochondrial Ca2+ uniporter. Cell Metabolism 17(6), 976987.
Depp, C, Bas-Orth, C, Schroeder, L, Hellwig, A and Bading, H (2018) Synaptic activity protects neurons against calcium-mediated oxidation and contraction of mitochondria during excitotoxicity. Antioxidants and Redox Signaling 29(12), 11091124.
De Stefani, D, Raffaello, A, Teardo, E, Szabò, I and Rizzuto, R (2011) A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter. Nature 476(7360), 336.
DiMauro, S (2004) Mitochondrial diseases. Biochimica et Biophysica Acta (BBA) – Bioenergetics 1658(1–2), 8088.
Etcheberrigaray, R, Hirashima, N, Nee, L, Prince, J, Govoni, S, Racchi, M, Tanzi, RE and Alkon, DL (1998) Calcium responses in fibroblasts from asymptomatic members of Alzheimer’s disease families. Neurobiology of Disease 5(1), 3745.
Gherardi, G, Nogara, L, Ciciliot, S, Fadini, GP, Blaauw, B, Braghetta, P, Bonaldo, P, De Stefani, D, Rizzuto, R and Mammucari, C (2018) Loss of mitochondrial calcium uniporter rewires skeletal muscle metabolism and substrate preference. Cell Death and Differentiation 26(2), 1.
Gibson, GE and Thakkar, A (2017) Interactions of mitochondria/metabolism and calcium regulation in Alzheimer’s disease: a calcinist point of view. Neurochemical Research 42(6), 16361648.
Giorgi, C, Agnoletto, C, Bononi, A, Bonora, M, De Marchi, E, Marchi, S, Missiroli, S, Patergnani, S, Poletti, F, Rimessi, A, Suski, JM, Wieckowski, MR and Pinton, P (2012) Mitochondrial calcium homeostasis as potential target for mitochondrial medicine. Mitochondrion 12(1), 7785.
Görlach, A, Bertram, K, Hudecova, S and Krizanova, O (2015) Calcium and ROS: a mutual interplay. Redox Biology 6, 260271.
Harrington, JL and Murphy, E (2015) The mitochondrial calcium uniporter: mice can live and die without it. Journal of Molecular and Cellular Cardiology 78, 4653.
Hawking, ZL (2016) Alzheimer’s disease: the role of mitochondrial dysfunction and potential new therapies. Bioscience Horizons: The International Journal of Student Research, 9, hzw014.
Kannurpatti, SS (2017) Mitochondrial calcium homeostasis: implications for neurovascular and neurometabolic coupling. Journal of Cerebral Blood Flow and Metabolism 37(2), 381395.
Kwon, S-K, Sando, III R, Lewis, TL, Hirabayashi, Y, Maximov, A and Polleux, F (2018) Correction: LKB1 regulates mitochondria-dependent presynaptic calcium clearance and neurotransmitter release properties at excitatory synapses along cortical axons. PLoS Biology 16(9), e3000040.
Liao, Y, Dong, Y and Cheng, J (2017) The function of the mitochondrial calcium uniporter in neurodegenerative disorders. International Journal of Molecular Sciences 18(2), 248.
Liao, Y, Hao, Y, Chen, H, He, Q, Yuan, Z and Cheng, J (2015) Mitochondrial calcium uniporter protein MCU is involved in oxidative stress-induced cell death. Protein & Cell 6(6), 434442.
Lin, MT and Beal, MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443(7113), 787.
Litersky, JM, Johnson, GV, Jakes, R, Goedert, M, Michael, L and Seubert, P (1996) Tau protein is phosphorylated by cyclic AMP-dependent protein kinase and calcium/calmodulin-dependent protein kinase II within its microtubule-binding domains at Ser-262 and Ser-356. Biochemical Journal 316(2), 655660.
Liu, JC, Liu, J, Holmström, KM, Menazza, S, Parks, RJ, Fergusson, MM, Yu, ZX, Springer, DA, Halsey, C, Liu, C, Murphy, E and Finkel, T (2016) MICU1 serves as a molecular gatekeeper to prevent in vivo mitochondrial calcium overload. Cell Reports 16(6):15611573.
Logan, CV, Szabadkai, G, Sharpe, JA, Parry, DA, Torelli, S, Childs, A-M, Kriek, M, Phadke, R, Johnson, CA, Roberts, NY, Bonthron, DT, Pysden, KA, Whyte, T, Munteanu, I, Foley, AR, Wheway, G, Szymanska, K, Natarajan, S, Abdelhamed, ZA, Morgan, JE, Roper, H, Santen, GW, Niks, EH, van der Pol, WL, Lindhout, D, Raffaello, A, De Stefani, D, den Dunnen, JT, Sun, Y, Ginjaar, I, Sewry, CA, Hurles, M, Rizzuto, R UK10K Consortium, Duchen, MR, Muntoni, F and Sheridan, E (2014) Loss-of-function mutations in MICU1 cause a brain and muscle disorder linked to primary alterations in mitochondrial calcium signaling. Nature Genetics 46(2), 188.
Lovell, MA, Xiong, S, Xie, C, Davies, P and Markesbery, WR (2004) Induction of hyperphosphorylated tau in primary rat cortical neuron cultures mediated by oxidative stress and glycogen synthase kinase-3. Journal of Alzheimer’s Disease 6(6), 659671.
Mallilankaraman, K, Doonan, P, Cárdenas, C, Chandramoorthy, HC, Müller, M, Miller, R, Hoffman, NE, Gandhirajan, RK, Molgó, J, Birnbaum, MJ, Rothberg, BS, Mak, DO, Foskett, JK and Madesh, M (2012) MICU1 is an essential gatekeeper for MCU-mediated mitochondrial Ca2+ uptake that regulates cell survival. Cell 151(3), 630644.
Mammucari, C, Gherardi, G, Zamparo, I, Raffaello, A, Boncompagni, S, Chemello, F, Cagnin, S, Braga, A, Zanin, S, Pallafacchina, G, Zentilin, L, Sandri, M, De Stefani, D, Protasi, F, Lanfranchi, G and Rizzuto, R (2015) The mitochondrial calcium uniporter controls skeletal muscle trophism in vivo. Cell Reports 10(8), 12691279.
M’Angale, P and Staveley, B (2017) Inhibition of mitochondrial calcium uptake 1 in Drosophila neurons. Genetics and Molecular Research 16(1), 104238.
Moreira, PI, Carvalho, C, Zhu, X, Smith, MA and Perry, G (2010) Mitochondrial dysfunction is a trigger of Alzheimer’s disease pathophysiology. Biochimica et Biophysica Acta (BBA) – Molecular Basis of Disease 1802(1), 210.
Nakamura, S, Takamura, T, Matsuzawa-Nagata, N, Takayama, H, Misu, H, Noda, H, Nabemoto, S, Kurita, S, Ota, T, Ando, H, Miyamoto, K and Kaneko, S (2009) Palmitate induces insulin resistance in H4IIEC3 hepatocytes through reactive oxygen species produced by mitochondria. The Journal of Biological Chemistry 284(22), 1480914818.
Nichols, M, Elustondo, PA, Warford, J, Thirumaran, A, Pavlov, EV and Robertson, GS (2017) Global ablation of the mitochondrial calcium uniporter increases glycolysis in cortical neurons subjected to energetic stressors. Journal of Cerebral Blood Flow and Metabolism 37(8), 30273041.
Pan, X, Liu, J, Nguyen, T, Liu, C, Sun, J, Teng, Y, Fergusson, MM, Rovira, II, Allen, M, Springer, DA, Aponte, AM, Gucek, M, Balaban, RS, Murphy, E and Finkel, T (2013) The physiological role of mitochondrial calcium revealed by mice lacking the mitochondrial calcium uniporter. Nature Cell Biology 15(12), 1464.
Payne, BA and Chinnery, PF (2015) Mitochondrial dysfunction in aging: much progress but many unresolved questions. Biochimica et Biophysica Acta (BBA) – Bioenergetics 1847(11), 13471353.
Piaceri, I, Rinnoci, V, Bagnoli, S, Failli, Y and Sorbi, S (2012) Mitochondria and Alzheimer’s disease. Biochimica et Biophysica Acta (BBA) ‐ Molecular Basis of Disease 322(1), 3134.
Picone, P, Nuzzo, D, Caruana, L, Scafidi, V and Di Carlo, M (2014) Mitochondrial dysfunction: different routes to Alzheimer’s disease therapy. Oxidative Medicine and Cellular Longevity 2014(2), 780179.
Pierrot, N, Ghisdal, P, Caumont, A and Octave, J (2004) Intraneuronal amyloid‐β1‐42 production triggered by sustained increase of cytosolic calcium concentration induces neuronal death. Journal of Neurochemistry 88(5), 11401150.
Praticò, D, Lee, VM-Y, Trojanowski, JQ, Rokach, J and Fitzgerald, GA (1998) Increased F2-isoprostanes in Alzheimer’s disease: evidence for enhanced lipid peroxidation in vivo. The FASEB Journal 12(15), 17771783.
Qiu, J, Tan, Y-W, Hagenston, AM, Martel, M-A, Kneisel, N, Skehel, PA, Wyllie, DJ, Bading, H and Hardingham, GE (2013) Mitochondrial calcium uniporter Mcu controls excitotoxicity and is transcriptionally repressed by neuroprotective nuclear calcium signals. Nature Communications 4, 2034.
Rasola, A and Bernardi, P (2007) The mitochondrial permeability transition pore and its involvement in cell death and in disease pathogenesis. Apoptosis 12(5), 815833.
Shuttleworth, CW, Brennan, AM and Connor, JA (2003) NAD (P) H fluorescence imaging of postsynaptic neuronal activation in murine hippocampal slices. The Journal of Neuroscience 23(8), 31963208.
Soman, S, Keatinge, M, Moein, M, Da Costa, M, Mortiboys, H, Skupin, A, Sugunan, S, Bazala, M, Kuznicki, J and Bandmann, O (2017) Inhibition of the mitochondrial calcium uniporter rescues dopaminergic neurons in pink1−/− zebrafish. The European Journal of Neuroscience 45(4), 528535.
Supnet, C and Bezprozvanny, I (2010) The dysregulation of intracellular calcium in Alzheimer disease. Cell Calcium 47(2), 183189.
Tamagno, E, Parola, M, Bardini, P, Piccini, A, Borghi, R, Guglielmotto, M, Santoro, G, Davit, A, Danni, O, Smith, MA, Perry, G and Tabaton, M (2005) β‐Site APP cleaving enzyme up‐regulation induced by 4‐hydroxynonenal is mediated by stress‐activated protein kinases pathways. Journal of Neurochemistry 92(3), 628636.
Trifunovic, A and Larsson, N (2008) Mitochondrial dysfunction as a cause of ageing. Journal of Internal Medicine 263(2), 167178.
Verma, M, Callio, J, Otero, PA, Sekler, I, Wills, ZP and Chu, CT (2017) Mitochondrial calcium dysregulation contributes to dendrite degeneration mediated by PD/LBD-associated LRRK2 mutants. The Journal of Neuroscience 37(46), 1115111165.
Waldeck-Weiermair, M, Malli, R, Parichatikanond, W, Gottschalk, B, Madreiter-Sokolowski, CT, Klec, C, Rost, R and Graier, WF (2015) Rearrangement of MICU1 multimers for activation of MCU is solely controlled by cytosolic Ca2+ . Scientific Reports 5, 15602.
Wang, X, Su, B, Lee, H, Li, X, Perry, G, Smith, MA and Zhu, X (2009) Impaired balance of mitochondrial fission and fusion in Alzheimer’s disease. The Journal of Neuroscience 29(28), 90909103.
Yao, J, Irwin, RW, Zhao, L, Nilsen, J, Hamilton, RT and Brinton, RD (2009) Mitochondrial bioenergetic deficit precedes Alzheimer’s pathology in female mouse model of Alzheimer’s disease. Proceedings of the National Academy of Sciences 106(34), 1467014675.


Mitochondrial calcium uniporter as a potential therapeutic strategy for Alzheimer’s disease

  • Anila Venugopal (a1), Mahalaxmi Iyer (a2), Venkatesh Balasubramanian (a1) and Balachandar Vellingiri (a1)


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed